-
Great news
@imulibrary! We hope your patrons enjoy using#AdisInsight. Let us know if there's anything we can do to help with the trial. -
It's day two
@PharmaCIConf, don’t forget to visit our booth and get your FREE competitive intelligence report.#pharmaciconf#competitiveintelligence#AdisInsight pic.twitter.com/Y2mC7mCSPA
-
Stop by our booth today
@PharmaCIConf USA to see how#AdisInsight can help you and receive a FREE competitive intelligence report.#pharmaciconf -
#AdisInsight you don't say much as you were the one that said#playthegamehttps://twitter.com/Deep__AI/status/1115827839142649856 … -
#AccessInAction and 3#inocent#chilldren.#mentalillnesssupportnetwork#AdisInsight had a good run with the 10000 annalized it.#all my work and then#targeted to#moc me with a offer of the#first leadership#ProjectDRIPP in#wales#timetochangPrikaži ovu nit -
Are you attending
@PharmaCIConf Asia this December? Visit us at our stand to see how#AdisInsight can help you and receive a FREE competitive intelligence report. To find out more and to pre-register your interest, click here: http://bit.ly/2XIHjEv#PharmaCIpic.twitter.com/dSw24WZx7R
-
Whatever your involvement in the world of drug-development, you need reliable data to help you make informed decisions. How about requesting your
#Adisinsight trial TODAY! To explore 210,000+ records on#drugs,#trials,#deals and#safety. http://bit.ly/2SJmb1E pic.twitter.com/JtGKc85sJB
-
Conheça a plataforma
#AdisInsight voltada para profissionais de farmacovigilância, qualidade e assuntos regulatórios http://bit.ly/2n77KjN pic.twitter.com/n027bZwaDG
-
Die Live-Demo für
#AdisInsight am Springer-Stand 57 beginnt jetzt gerade.#bibtag15pic.twitter.com/ilTlcgGQc2
-
#AdisInsight Datenbank Arzneimittelforschung/-Entwicklung Live-Präsentation heute 16 Uhr am#Springer Stand 57#bibtag15 -
Assista o vídeo de apresentação dos recursos da nova plataforma
#AdisInsight http://bit.ly/1DACrA4#Springer http://fb.me/3hlY2K1Wl
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.